Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
Executives will discuss the company’s portfolio and pipeline, and the webcast replay will remain available for about one month.
- The 2026 Jefferies Global Healthcare Conference in London will feature presentations from biotechnology companies Neurocrine Biosciences and Lycia Therapeutics next week.
- On Tuesday, November 17, 2026, Neurocrine executives will present at 3:30 p.m. Greenwich Mean Time, focusing on treating complex neurological and immunological disorders.
- Lycia President and Chief Executive Officer Aetna Wun Trombley will present on Wednesday, November 18, 2026, at 3:00 p.m. Greenwich Mean Time, discussing protein degradation research.
- Interested investors can access live webcasts through the companies' respective websites, with replays available approximately one hour after each session and archived for one month.
- With more than three decades of experience, Neurocrine applies insights into brain and body systems to treat complex conditions, positioning the company as a leader in neuroscience innovation.
23 Articles
23 Articles
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing…
Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
SAN DIEGO, Nov. 10, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the 2026 Jefferies Global Healthcare Conference in London at 3:30 p.m. Greenwich Mean Time (10:30 a.m. Eastern Time) on November…
Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
CHARLESTOWN, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the 'Company” or 'Solid”), a life sciences company developing precision genetic...
Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London - Beacon Therapeutics
Related posts: Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona’s Patented AAV204 Capsid for Select Ophthalmology Indications Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer Beacon Therapeutics Announces Positive Interim 9+ Month Results from DAWN Trial and 36-Month […]
Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00 p.m. (GMT). A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at telefle. About Teleflex Incorporated As a more...
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
